Emergent BioSolutions Inc. — Director's Dealing 2025

Apr 10, 2025

SEC Form 4/A — Form 4/A

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2025-03-06

Reporting Person: Hartzel William (SVP, Bioservices)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-06	Common Stock	A	62500	—	Acquired	109683	Direct

Footnotes

F1: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the day prior to the anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

F2: This Form 4/A is filed solely to correct the previously reported amount of securities beneficially owned following the reported transaction. The original Form 4 filing reported 109,975 due to a clerical error.